{
  "$schema": "folio-library-entry/v1",
  "id": "10665-266214",
  "blocks": [
    {
      "id": "library/10665-266214/blocks/prose-sec-000",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "APEROU HISTORIQUE",
      "pageStart": 1,
      "pageEnd": 5,
      "target": "../sections/sec-000-1-aperou-historique.md",
      "narrative": null,
      "content": "Dans 1'ancienne Chine deja, on procedait 'a la variolisation en soufflant\ndans le nez des crofites varioliques dessechees et pulverisees. Dans d'autres\npays egalement, on employa plus tard, pour la vaccination, des crofites\ndessechees ou la lymphe des pustules s&chee sur de l'etoffe, du verre, du\nmetal, de l'ivoire ou du bois. Jenner lui-meme proceda de cette maniere\nlorsqu'il envoya 'a Ferro,20 a titre d'exemple, du vaccin desseche sur des\nfils, au moyen duquel son correspondant vaccina\nses propres enfants.\nLe medecin vaccinateur de Carro,15 a Vienne, recut, lui aussi, sous la meme\nforme, du",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Gives a historical overview, in French, of preserving smallpox vaccine by drying, from early variolation with dried scabs and Jenner's dried vaccine on threads to nineteenth-century use of ivory points. It reviews successive drying techniques and reported storage times, moving on to vacuum and freeze-drying methods developed by various researchers in the twentieth century. The section ends with improvements such as purified dried vaccines prepared with antiseptics or tyrothricin.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-266214/blocks/prose-sec-front-matter",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Front matter",
      "pageStart": 1,
      "pageEnd": 1,
      "target": "../sections/sec-front-matter.md",
      "narrative": null,
      "content": "Bull. Org. mond. SantS?\n1952, 5, 127-147\nBull. World Hith Org.\nVACCINS ANTIVARIOLIQUES SECS\nPreparation du vaccin d'Otten\na l'Institut Pasteur de Bandoeng, Indonesie\nDr W. A. COLLIER\nChef du Laboratoire de Bacteriologie du Gouvernement, Paramaribo, Surinam\nAncien Chef du Service de la\nVariole\na' l'Institut Pasteur de Bandoeng, Indonesie\nManuscrit requ en novembre 1950\nLes experiences faites pendant la guerre et l'augmentation des cas de\nvariole au cours de ces dernieres annees ont rappele l'attention des hygie-\nnistes sur l'importance que revet un vaccin antivariolique dont les pro-\nprietes so",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "The title page and introduction of a 1952 Bulletin of the World Health Organization article (in French) on dried smallpox vaccine, describing preparation of Otten's vaccine at the Pasteur Institute in Bandung, Indonesia. It explains that a heat-stable dried vaccine is needed for worldwide shipment and that over 26 million doses of Otten's vaccine were supplied in 1949.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-266214/blocks/prose-sec-001",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "LE VACCIN SEC D'OTTEN ET SA PRaPARATION",
      "pageStart": 5,
      "pageEnd": 13,
      "target": "../sections/sec-001-2-le-vaccin-sec-dotten-et-sa-praparation.md",
      "narrative": null,
      "content": "LE VACCIN SEC D'OTTEN ET SA PRaPARATION\n2.1 Qualites du vaccin\nLe vaccin sec d'Otten ne represente, en principe, rien de nouveau.\nLe grand merite d'Otten est d'avoir procede pendant des annees a l'etude\nminutieuse de chacun des elements qui presentent de l'importance pour\nla fabrication du vaccin, de sorte que nous sommes aujourd'hui en mesure\nde preparer des vaccins secs en quantites pratiquement illimitees et d'une\nmaniere extremement economique. I1 est devenu de plus en plus manifeste\nque le vaccin sec prepare suivant le procede d'Otten est le seul qui permette\nd'immuniser systematiquement",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Describes the qualities of Otten's dried smallpox vaccine, stressing that it keeps its potency for years whatever the climate and can be produced cheaply in large quantities and stockpiled. It then sets out the preparation technique at the Bandung institute, covering the vaccine strain and its maintenance in buffalo, harvesting of pulp, drying, filling of ampoules and quality control. Results of tests on old stored batches show that most ampoules from the late 1920s remained virulent.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-266214/blocks/prose-sec-002",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "POUVOIR D'HIIMAGGLUTINATION, VIRULENCE ET POUVOIR ANTI-",
      "pageStart": 13,
      "pageEnd": 14,
      "target": "../sections/sec-002-i-pouvoir-dhiimagglutination-virulence-et-pouvoi.md",
      "narrative": null,
      "content": "GgNIQUE DU VACCIN ANTIVARIOLIQUE SEC PR9PAR9 SUR LE BUFFLE ET AGg\nDE 4 A 6 MOIS\nVirulence\nd6terminee sur la cornee du\nAntihemagglutination\nNumero\ncobaye avec une dilution\nconstatee aprbs\ndu\nlot\nH6magglu-\ndu vaccin de\nde\ntination\nvaccin\n1/100\n1/1000\n1/10000 1/100000\n12 jours\n20 jours\n30 jours\nDilution\nDilution maximum du strum\nmaximum\nde cby\ndu virus\ncobaye\n563\n1600\n+\n+\n+\n0\n96\n420\n68\n573\n3200\n+\n+\n+\n+\n140\n820\n62\n576\n1600\n+\n+\n+\n0\n38\n220\n55\n580\n1600\n+\n+\n+\n0\n84\n480\n80\n583\n3200\n+\n+\n+\n+\n172\n660\n110\n603\n3200\n+\n+\n0\n0\n180\n880\n120\n606\n1600\n+\n+\n+\n+\n168\n500\n133\n607\n1600\n+\n+\n+\n0\n52\n460\n87\n608\n1600\n+\n+\n+\n0\n2",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "A table of haemagglutination, virulence on guinea-pig cornea and antigenic potency for batches of dried smallpox vaccine prepared on buffalo and aged 4 to 6 months.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-266214/blocks/prose-sec-003",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "POUVOIR D'HgMAGGLUTINATION, VIRULENCE ET POUVOIR ANTI-",
      "pageStart": 14,
      "pageEnd": 16,
      "target": "../sections/sec-003-ii-pouvoir-dhgmagglutination-virulence-et-pouvoi.md",
      "narrative": null,
      "content": "GINIQUE DU VACCIN ANTIVARIOLIQUE SEC PREPARt SUR LE BUFFLE ET AGI\nDE PLUSIEURS ANNEES\nVirulence d6termin6e\nAthmgltnto\nNumoro\nsur la corn6e du cobaye\nAntsi6maggt\nnat\ndu\nlot\nDate de\nH-1maggluti-\navec une dilution du vaccin de\ncnttears\nde\npr6paration\nnation\nvaccin\ndu vaccin\n1/100\n1/1.000\n1/10000 1/100000 12 jours 20 jours 30 jours\nDilution\nDilution maximum\nmaximum\ndu serum de cobaye\ndu virus\n23\n5.1926\n3200\n0\n0\n0\n0\n22\n45\n25\n31\n8.1927\n1280\n+\n0\n0\n0\n13\n22\n80\n31\n8.1927\n1280\n+\n0\n0\n0\n76\n152\n410\n31\n8.1927\n1600\n+\n+\n+\n0\n106\n120\n36\n31\n8.1927\n1600\n+\n+\n+\n0\n368\n368\n104\n25\n1928\n640\n+\n0\n0\n0\n20\n26\n16\n26\n6.1928\n16",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Tabulates haemagglutination, virulence and antigenic potency for dried smallpox vaccine batches several years to decades old, dating from 1926 onward. The accompanying text reports primary vaccination trials in 1948 with vaccine about 18 years old, which still produced positive reactions in 30% to 84.6% of children.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-266214/blocks/prose-sec-004",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "RgSULTATS DE PRIMO-VACCINATIONS EFFECTUgES AVEC UN",
      "pageStart": 16,
      "pageEnd": 17,
      "target": "../sections/sec-004-iv-rgsultats-de-primo-vaccinations-effectuges-av.md",
      "narrative": null,
      "content": "VACCIN SEC AGI\nDE 18 ANS\nNum6ro du lot\nNombre d'enfants\nR6sultats\npositifs\nde vaccin\nvaccin6s\nNombre\nPourcentage\n9/1930\n13\n11\n84,6\n9/1930\n15\n7\n46,7\n10/1930\n23\n18\n78,3\n10/1930\n15\n12\n80\n11/1930\n25\n13\n52\n11/1930\n20\n7\n35\n12/1930\n13\n5\n38,5\n12/1930\n10\n3\n30\n13/1930\n17\n7\n41,2\n13/1930\n8\n6\n75\nnombreux. Sur les 10 specimens soumis a l'epreuve, 4 ont donne des reac-\ntions vaccinales primaires chez plus de 70% des enfants vaccines.\nI1 va sans dire, repetons-le, que des vaccins desseches aussi ages ne sont\njamais utilises en pratique. L'experience demontre toutefois d'une maniere\nirrefutable le haut pouvoir",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Presents results of primary vaccinations with 18-year-old dried vaccine, showing that several batches still produced reactions in most children, and begins a section on large-scale production in Indonesia. It notes that output was increased sharply during a major smallpox epidemic, while normal annual use is about 10 million doses.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-266214/blocks/prose-sec-005",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "NOMBRE DES DISTRICTS AYANT UTILIS9 LE VACCIN SEC ET",
      "pageStart": 17,
      "pageEnd": 19,
      "target": "../sections/sec-005-v-nombre-des-districts-ayant-utilis9-le-vaccin-s.md",
      "narrative": null,
      "content": "NOMBRE DE DOSES DE VACCINS DgLIVRgES DE 1931 A 1941\nNombre de districts\nDoses de vaccin\nAnn6e\nde vaccination\nd6livr6es\n1931\n13\n147.000\n1932\n16\n149.775\n1933\n32\n356.800\n1934\n37\n452.800\n1935\n44\n420.900\n1936\n47\n539.600\n1937\n52\n587.000\n1938\n966.200\n1939\n656.200\n1940\n69\n705.500\n1941\n71\n801.700\nLa fabrication de ce dernier n'est pas plus couteuse que celle du vaccin\nglycerine. II n'est naturellement pas possible de calculer exactement son\nprix de revient, car, suivant les pays, le prix du verre et d'autres matieres\npremieres, le prix d'achat des animaux et surtout les salaires du personnel\ndifferent",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Tabulates the number of districts using the dried vaccine and doses delivered from 1931 to 1941, rising from 147,000 to about 800,000. It states that the vaccine is no more costly to make than glycerinated vaccine and then explains how vaccinators should reconstitute and use it, including how long suspensions may be kept at room temperature or in a refrigerator.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-266214/blocks/prose-sec-006",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "SUMMARY",
      "pageStart": 19,
      "pageEnd": 21,
      "target": "../sections/sec-006-summary.md",
      "narrative": null,
      "content": "RE2SUMEJ\nA dried smallpox vaccine has the ad-\nvantages that it can be prepared on a large\nscale, kept, and transported to all parts of\nthe world without losing its potency. The\ndried vaccine made by Otten's method at\nthe Institute Pasteur, Bandoeng, has been\nused in Indonesia since 1931 for vaccinat-\ning the local population.\nThe number of\ndoses of vaccine supplied rose from 147,000\nin 1931 to 801,700 in 1941 and to more\nthan 26 million in 1949.\nAfter an historical survey dealing with\nthe various empirical or scientific methods\nof vaccination by means of dried vaccine,\nthe author describes in",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "The English and French summaries of the dried smallpox vaccine article, recounting the growth of Otten's vaccine use in Indonesia and the adaptation of the vaccine strain to buffalo. They outline how pulp is ground, dried under vacuum, powdered and sealed in ampoules, and how purity, virulence and antigenic potency are tested. The summaries report that the vaccine remained effective after 18 years of storage, and the block closes with the article's reference list.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    }
  ]
}
